Quality Assurance

Within the framework of  clinical checks new possible treatments for the therapy of illnesses are investigated. The effectiveness but also the ineffectiveness of the application of already non-authorized medicines are determined.

Compliance with the international guidelines of  Good Clinical Practice (GCP), the law governing the manufacture and prescription of  drugs and the data protection act, are prerequisites and conditions of the implementation of  our clinical studies.

We are bound to the continuous and sustainable achievement of these standards.